Stay up to date with notifications from TheĀ Independent

Notifications can be managed in browser preferences.

4th death, more vision loss cases linked to tainted eyedrops

U.S. health officials are reporting another death and several more cases of vision loss linked to eyedrops tainted with a drug-resistant bacteria

Mike Stobbe
Friday 19 May 2023 16:20 EDT
Eyedrops Recall
Eyedrops Recall

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

U.S. health officials reported another death and several more cases of vision loss from illnesses linked to eyedrops tainted with a drug-resistant bacteria.

The bacteria has infected 81 people, including four who died and 14 who lost vision, the Centers for Disease Control and Prevention said Friday. Thatā€™s up from three deaths and eight cases of vision loss reported in March. The CDC also said four people have undergone surgery to remove an eyeball due to the infections.

The outbreak is considered particularly worrisome because the bacteria driving it ā€” Pseudomonas aeruginosa ā€” is resistant to standard antibiotics.

Investigators say most of the patients had used certain brands of eyedrops, and products from EzriCare and Delsam Pharma were recalled in February. At least seven patients were diagnosed after the recall.

After the recall, U.S. health inspectors visited the plant in India that made the eyedrops and uncovered problems with how the drops were made and tested, including inadequate sterility measures.

Cases have been reported from 18 states ā€” California, Colorado, Connecticut, Delaware, Florida, Illinois, North Carolina, New Jersey, New Mexico, Nevada, New York, Ohio, Pennsylvania, South Dakota, Texas, Utah, Washington and Wisconsin.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Instituteā€™s Science and Educational Media Group. The AP is solely responsible for all content.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in